Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-3-6
pubmed:abstractText
An autoregulated tetracycline-inducible recombinant adeno-associated viral vector (rAAV-pTet(bidi)ON) utilizing the rtTAM2 reverse tetracycline transactivator (rAAV-rtTAM2) was used to conditionally express the human GDNF cDNA. Doxycycline, a tetracycline analog, induced a time- and dose-dependent release of GDNF in vitro in human glioma cells infected with rAAV-rtTAM2 serotype 2 virus. Introducing the Woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) downstream to the rtTAM2 coding sequence, resulted in a more rapid induction and a higher basal expression level. In vivo, 8 weeks after a single injection of the rAAV-rtTAM2-GDNF vector encapsidated into AAV serotype 1 capsids in the rat striatum, the GDNF protein level was 60 pg/mg tissue in doxycycline-treated animals whereas in untreated animals, it was undistinguishable from the endogenous level ( approximately 4 pg/mg tissue). However, a residual GDNF expression in the uninduced animals was evidenced by a sensitive immunohistochemical staining. As compared to rAAV1-rtTAM2-GDNF, the rAAV1-rtTAM2-WPRE-GDNF vector expressed a similar concentration of GDNF in the induced state (with doxycycline) but a basal level (without doxycycline) approximately 2.5-fold higher than the endogenous striatal level. As a proof for biological activity, for both vectors, downregulation of tyrosine hydroxylase was evidenced in dopaminergic terminals of doxycycline-treated but not untreated animals. In conclusion, the rAAV1-rtTAM2 vector which expressed biologically relevant doses of GDNF in the striatum in response to doxycycline with a basal level undistinguishable from the endogenous striatal level, as measured by quantitative ELISA assay, constitutes an interesting tool for local conditional transgenesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0014-4886
pubmed:author
pubmed:issnType
Print
pubmed:volume
204
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
387-99
pubmed:meshHeading
pubmed-meshheading:17223106-Animals, pubmed-meshheading:17223106-Brain, pubmed-meshheading:17223106-Cell Line, Tumor, pubmed-meshheading:17223106-Corpus Striatum, pubmed-meshheading:17223106-DNA, Complementary, pubmed-meshheading:17223106-Dependovirus, pubmed-meshheading:17223106-Dose-Response Relationship, Drug, pubmed-meshheading:17223106-Down-Regulation, pubmed-meshheading:17223106-Doxycycline, pubmed-meshheading:17223106-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:17223106-Female, pubmed-meshheading:17223106-Gene Expression, pubmed-meshheading:17223106-Gene Transfer Techniques, pubmed-meshheading:17223106-Genetic Vectors, pubmed-meshheading:17223106-Glial Cell Line-Derived Neurotrophic Factor, pubmed-meshheading:17223106-Green Fluorescent Proteins, pubmed-meshheading:17223106-Humans, pubmed-meshheading:17223106-Immunohistochemistry, pubmed-meshheading:17223106-Injections, pubmed-meshheading:17223106-Rats, pubmed-meshheading:17223106-Rats, Sprague-Dawley, pubmed-meshheading:17223106-Tetracyclines, pubmed-meshheading:17223106-Time Factors, pubmed-meshheading:17223106-Transduction, Genetic, pubmed-meshheading:17223106-Transgenes, pubmed-meshheading:17223106-Tyrosine 3-Monooxygenase
pubmed:year
2007
pubmed:articleTitle
Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
pubmed:affiliation
Laboratory of Experimental Neurosurgery, Multidisciplinary Research Institute (IRIBHM) Université Libre de Bruxelles, Hôpital Erasme, Belgium.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't